Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05929820 · ClinicalTrials.gov registry record · NA
Impact of Protect Your Colon™ on CRC Screening
A NA study of Colorectal Cancer Screening, sponsored by Cedars-Sinai Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 184
- Enrollment target
- 1
- Study location
NCT05929820: Recruiting NA study of Colorectal Cancer Screening, sponsored by Cedars-Sinai Medical Center.
NCT05929820 is a NA study of Colorectal Cancer Screening that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 184 participants, below the 5,873-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05929820, a NA study of Colorectal Cancer Screening, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 184 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the research is to assess the impact of Protect Your Colon™, a colorectal cancer (CRC) screening decision aid, on patients' CRC screening behaviors. The Investigators hypothesize that Protect Your Colon™, through optimizing shared decision making, will lead to selection of a test that accurately matches patients' values and increase CRC screening uptake. To test this hypothesis, the investigators will conduct a pilot randomized controlled trial (RCT) to assess if provision of Protect Your Colon™ improves communication on CRC screening, intent to complete screening, and ultimately uptake of screening vs. usual care.
Primary Outcome
Uptake of CRC screening within 6 months of patients' initial visit
Conditions Studied
Interventions
- BEHAVIORAL Protect Your Colon™
Study Locations (1)
California
- Cedars-Sinai Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2023-09-28 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT05929820 shows while recruiting
NCT05929820 is an interventional study that assigns participants to a tested intervention. The registered 184 participants enrollment target is mid-sized for trials with a published cap, below the 5,873-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Colorectal Cancer Screening appearing as the primary indexed condition, and to 1 intervention - of which Protect Your Colon™ is the first listed.
NCT05929820 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05929820 about?
NCT05929820 is a clinical study titled "Impact of Protect Your Colon™ on CRC Screening". The purpose of the research is to assess the impact of Protect Your Colon™, a colorectal cancer (CRC) screening decision aid, on patients' CRC screening behaviors. The Investigators hypothesize that Protect Your Colon™, through optimizing shared decision making, will lead to selection of a test that...
What is the current status of trial NCT05929820?
This trial is currently recruiting. It is a NA study. The enrollment target is 184 participants. The study started on 2023-09-28. Estimated completion is 2026-06-30.
What conditions does trial NCT05929820 study?
This clinical trial studies the following conditions: Colorectal Cancer Screening.
What interventions are being tested in trial NCT05929820?
The interventions under investigation include: Protect Your Colon™ (BEHAVIORAL).
Who is sponsoring clinical trial NCT05929820?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05929820 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05929820's enrollment target sits among peer trials
184 13th of 19 higher than 7 of 19 other Colorectal Cancer Screening trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer Screening trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Use of a Colorectal Cancer Screening Decision Support Tool in Primary Care
RECRUITING · NA
-
Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening
RECRUITING · NA
-
Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening
RECRUITING · NA
-
Test Up Now Education Program
COMPLETED · NA
-
Multilevel Intervention Based on Colorectal Cancer (CRC) and Cervical Cancer Self-screening in Rural, Segregated Areas
COMPLETED · NA
-
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03903510 · 184 participants · NA
Virtual Reality During Pediatric Cast Removal
- NCT04020510 · 184 participants · Phase 4
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
- NCT04135846 · 184 participants · Phase 2
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
- NCT04396873 · 184 participants · Phase 1
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI